Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Glycosylation: a hallmark of cancer?
Bhairavi N. Vajaria, Prabhudas S. Patel
Glycoconjugate Journal (2016) Vol. 34, Iss. 2, pp. 147-156
Closed Access | Times Cited: 252

Showing 1-25 of 252 citing articles:

Exploration of the Sialic Acid World
Roland Schauer, Johannis P. Kamerling
Advances in carbohydrate chemistry and biochemistry (2018), pp. 1-213
Open Access | Times Cited: 286
Altered Cell Adhesion and Glycosylation Promote Cancer Immune Suppression and Metastasis
Heinz Laübli, Lubor Borsig
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 214
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
Jinfang Zhang, Fabin Dang, Junming Ren, et al.
Trends in Biochemical Sciences (2018) Vol. 43, Iss. 12, pp. 1014-1032
Open Access | Times Cited: 183
Glycosylation markers in cancer
Atit Silsirivanit
Advances in clinical chemistry (2019), pp. 189-213
Closed Access | Times Cited: 156
PD-1 regulation in immune homeostasis and immunotherapy
Minling Gao, Jie Shi, Xiangling Xiao, et al.
Cancer Letters (2024) Vol. 588, pp. 216726-216726
Closed Access | Times Cited: 18
Serum sialylation changes in cancer
Zejian Zhang, Manfred Wuhrer, Stephanie Holst
Glycoconjugate Journal (2018) Vol. 35, Iss. 2, pp. 139-160
Open Access | Times Cited: 157
Aberrant glycosylation and cancer biomarker discovery: a promising and thorny journey
Mengmeng Wang, Jianhui Zhu, David M. Lubman, et al.
Clinical Chemistry and Laboratory Medicine (CCLM) (2018) Vol. 57, Iss. 4, pp. 407-416
Open Access | Times Cited: 151
Endothelial E-selectin inhibition improves acute myeloid leukaemia therapy by disrupting vascular niche-mediated chemoresistance
Valérie Barbier, Johanna Erbani, Corrine E. Fiveash, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 135
O-GlcNAc in cancer: An Oncometabolism-fueled vicious cycle
John A. Hanover, Weiping Chen, Michelle Bond
Journal of Bioenergetics and Biomembranes (2018) Vol. 50, Iss. 3, pp. 155-173
Closed Access | Times Cited: 128
Recent Advances in Glycoproteomic Analysis by Mass Spectrometry
Suttipong Suttapitugsakul, Fangxu Sun, Ronghu Wu
Analytical Chemistry (2019) Vol. 92, Iss. 1, pp. 267-291
Open Access | Times Cited: 127
Golgi pH, Ion and Redox Homeostasis: How Much Do They Really Matter?
Sakari Kellokumpu
Frontiers in Cell and Developmental Biology (2019) Vol. 7
Open Access | Times Cited: 119
Selectin Ligands Sialyl-Lewis a and Sialyl-Lewis x in Gastrointestinal Cancers
Marco Trinchera, Adele Aronica, Fabio Dall’Olio
Biology (2017) Vol. 6, Iss. 1, pp. 16-16
Open Access | Times Cited: 111
The Diverse Contributions of Fucose Linkages in Cancer
Tyler Keeley, Shengyu Yang, Eric K. Lau
Cancers (2019) Vol. 11, Iss. 9, pp. 1241-1241
Open Access | Times Cited: 109
ST6GAL1: A key player in cancer (Review)
Rebecca Garnham, Emma Scott, Karen E. Livermore, et al.
Oncology Letters (2019)
Open Access | Times Cited: 105
E‐cadherin deregulation in breast cancer
Giovanni Corso, Joana Figueiredo, Simone Pietro De Angelis, et al.
Journal of Cellular and Molecular Medicine (2020) Vol. 24, Iss. 11, pp. 5930-5936
Open Access | Times Cited: 103
Glycoproteomics-based signatures for tumor subtyping and clinical outcome prediction of high-grade serous ovarian cancer
Jianbo Pan, Yingwei Hu, Shisheng Sun, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 101
CIBERSORT analysis of TCGA and METABRIC identifies subgroups with better outcomes in triple negative breast cancer
Kelly E. Craven, Yesim Gökmen–Polar, Sunil Badve
Scientific Reports (2021) Vol. 11, Iss. 1
Open Access | Times Cited: 95
Fucosylation in cancer biology and its clinical applications
Ming Shan, Dandan Yang, Huaiqian Dou, et al.
Progress in molecular biology and translational science (2019), pp. 93-119
Closed Access | Times Cited: 92
Aberrant Sialylation in Cancer: Biomarker and Potential Target for Therapeutic Intervention?
Silvia Pietrobono, Barbara Stecca
Cancers (2021) Vol. 13, Iss. 9, pp. 2014-2014
Open Access | Times Cited: 90
Targeting Aberrant Sialylation to Treat Cancer
Jennifer Munkley, Emma Scott
Medicines (2019) Vol. 6, Iss. 4, pp. 102-102
Open Access | Times Cited: 86
GPSeeker Enables Quantitative Structural N-Glycoproteomics for Site- and Structure-Specific Characterization of Differentially Expressed N-Glycosylation in Hepatocellular Carcinoma
Kaijie Xiao, Zhixin Tian
Journal of Proteome Research (2019) Vol. 18, Iss. 7, pp. 2885-2895
Closed Access | Times Cited: 81
ST3GAL1 is a target of the SOX2-GLI1 transcriptional complex and promotes melanoma metastasis through AXL
Silvia Pietrobono, Giulia Anichini, Cesare Sala, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 72
Coumarin-hemicyanine-based far-red to near-infrared fluorescent probes: A new generation of fluorescent probe design platform
Qiuling Sun, Deming He, Lishen Zhang, et al.
TrAC Trends in Analytical Chemistry (2023) Vol. 167, pp. 117272-117272
Closed Access | Times Cited: 34
Protein glycosylation alterations in hepatocellular carcinoma: function and clinical implications
Yifei Wang, Huarong Chen
Oncogene (2023) Vol. 42, Iss. 24, pp. 1970-1979
Open Access | Times Cited: 27
Novel banana lectin CAR-T cells to target pancreatic tumors and tumor-associated stroma
Mary K. McKenna, Ada Ozcan, Daniel Brenner, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 1, pp. e005891-e005891
Open Access | Times Cited: 24
Page 1 - Next Page

Scroll to top